Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial investigating the tolerability and efficacy of ralfinamide in patients with third molar, post-extraction dental pain

Next Previous
Trial Profile

Phase II trial investigating the tolerability and efficacy of ralfinamide in patients with third molar, post-extraction dental pain

Status: Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2008

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ralfinamide (Primary)
  • Indications Dental pain; Postoperative pain
  • Focus Therapeutic Use

Most Recent Events

  • 27 Mar 2008 Results will be reported at AAN 2008.
  • 19 Feb 2008 Status changed from recruiting to in progress, in accordance with media release 9085420.
  • 09 Oct 2007 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top